Outcomes of multiple sclerosis patients admitted with COVID-19 in a large veteran cohort

BACKGROUND: Given concerns over immune function, the decision whether to continue disease modifying therapy (DMT) in multiple sclerosis (MS) patients during the COVID-19 pandemic has been challenging, complicated by the risk of MS disease progression in the absence of treatment. METHODS: This retros...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuchs, Tom A., Wattengel, Bethany A., Carter, Michael T., El-Solh, Ali A., Lesse, Alan J., Mergenhagen, Kari A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B. V 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188116/
https://www.ncbi.nlm.nih.gov/pubmed/35724529
http://dx.doi.org/10.1016/j.msard.2022.103964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188116/
https://www.ncbi.nlm.nih.gov/pubmed/35724529
http://dx.doi.org/10.1016/j.msard.2022.103964

Ejemplares similares